CD40 and B-cell chronic lymphocytic leukemia: Dasatinib induces apoptosis in CLL B-cells in vitro, with U-CLL cells being more sensitive [50], and has also been shown to sensitize tumor cells to chlorambucil and fludarabine to overcome CD40-mediated drug resistance in vitro [51].